Kidney disease sufferers doubled in India in 15 years supriya kashyap kashyap21 Aug 2016 9:08 AM ISTNew Delhi : The number of Indians suffering from chronic kidney ailments has doubled in the past 15 years, and at present 17 in every hundred citizens...
Apixaban -A safer anticoagulant for AF patients on dialysis: Circulation Study Medha Baranwal Baranwal2 July 2018 8:20 PM ISTThe use of apixaban, an anticoagulant, in end-stage kidney disease (ESKD) patients with atrial fibrillation (AF) on dialysis, lowers the risk of major...
Canagliflozin not only lowers blood sugar but also reduces kidney failure risk in Diabetes Dr. Kartikeya14 April 2019 8:28 PM ISTIn Phase 3 CREDENCE study, researchers found that in patients of Diabetes, along with controlling blood sugar Canagliflozin reduced the risk of kidney...
Intensive BP lowering beneficial for type 2 diabetes patients Medha Baranwal Baranwal29 April 2019 8:15 PM ISTCHINA: Intensive blood pressure (BP) lowering treatment provides greater benefits in patients with type 2 diabetes compared with less intensive...
More than half of elderly CKD patients die within a year of beginning dialysis: JAMA Dr. Kartikeya30 April 2019 7:20 PM ISTMore than half of elderly patients of CKD die within a year of beginning dialysis and nearly one in four succumbed to the disease within a month of...
Heart failure patients at high risk of developing kidney failure Medha Baranwal Baranwal12 Jan 2020 7:15 PM ISTUSA: Cardiovascular disease (CVD), independent of kidney risk factors, increases the risk of developing kidney failure, finds a recent study published...
FDA approves canagliflozin to treat diabetic kidney disease in type 2 diabetes patients Deepanjana Sarkar1 Oct 2019 7:30 PM ISTThe drug regulatory body, U.S. Food and Drug Administration (FDA), has approved a new indication for canagliflozin and that is to reduce risk of...
